Effects of Vitamin D and Retinoids on Pancreatic Cancer Cells
Author Information
Author(s): G Zugmaier, R Jigerl, B Grage, MM Gottardis, K Havemann, C Knabbe
Primary Institution: Marburg University Medical Center
Hypothesis
The study investigates the growth-inhibitory effects of vitamin D analogue EB1089 and retinoids on human pancreatic cancer cell lines.
Conclusion
The combination of vitamin D analogue EB1089 and all-trans-retinoic acid significantly inhibits the growth of certain pancreatic cancer cell lines.
Supporting Evidence
- All-trans-retinoic acid inhibited the growth of Capan 1 and Capan 2 cells by 40%.
- The combination of 1 nM EB1089 with 10 nM all-trans-retinoic acid inhibited growth by 90% in Capan 1 cells.
- 9-cis-Retinoic acid was less effective than all-trans-retinoic acid.
- EB1089 alone did not significantly inhibit growth.
Takeaway
This study found that a mix of vitamin D and a type of vitamin A can help stop some pancreatic cancer cells from growing.
Methodology
The study used cell culture and proliferation assays to test the effects of vitamin D analogue EB1089 and retinoids on pancreatic cancer cell lines.
Limitations
The study did not include in vivo experiments to confirm the effects observed in vitro.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website